Interested to Buy Any Domain ? << Click Here >> for more details...
How do we fix the sample concentaryion in hplc method
development. what is the basis?Thanks in advance
- 4 Answers
- 20984 Views
- DRL, Glenmark, Orchid, I also Faced
- E-Mail Answers
Answer Posted / rajareddy
based on the peak response ,peak height and LOD and LOQ Signal. Ex:sample concentration 1mg/ml than LOQ value (0.1%mg/ml) LOD value(0.03mg/ml)
| Is This Answer Correct ? | 0 Yes | 0 No |
Post New Answer View All Answers
what is procedure of actual procedure for registration of drug?
how require to set assay concentration for standard and sample?
what is different when impergnated silica plates are used in separation of azo dyes using column chromatography?
how to selecet an exact coloumn for an new molecule development by hplc how to select exact salt as buffer for new molecule development by hplc what is the the process to select the mode of saparation of compoundes by hplc what is the use of ph of buffer what is use of buffer,ph,organic phase,ans methods how the molecules get saparated in coloumn,
what is turbidimetric titration?Give 2 examples.
If combination product how require to identify which imp is of which api?
What is the Formula for coreletion coefficient in plhplc calibration
can we use the same detector in HPLC as well GC and what could be the differences we can find in the final chromato graph in any aspects?
From where require to take the RLD sample?
which situation gc hs and gc als require to use?
In HPLC calibration, caffeine is used as primary standard for wave length calibration due to caffeine is having dual maxima at 273 & 205 nm and one minima at 245 nm. Any body can give reference of these details from any pharmacopeia (with chapter no.) or any other authentic guideline?
How we can identify process related and degradation impurity in single method with short period?
why sre you used Potassium hydrogen phthalate in standarisation of 1N NaOH and 0.1 N Perchloric Acid?
what is impurity profile. how to interpret this impurity profile to a drug product or drug substance.
inhouse product is in capsule form in combination and RLD is in tablet form then can we proceed for multimedia CDP? in inhouse capsule product disso is paddle with sinker in release media is there then RLD product in tablet form then with same as paddle with sinker we can proceed n.a.?
